DK159328C - Fremgangsmaade til fremstilling af cholesterolsynteseinhiberende 3-hydroxy-ml-236b derivater, betegnet m-4 og m-4' - Google Patents
Fremgangsmaade til fremstilling af cholesterolsynteseinhiberende 3-hydroxy-ml-236b derivater, betegnet m-4 og m-4'Info
- Publication number
- DK159328C DK159328C DK516182A DK516182A DK159328C DK 159328 C DK159328 C DK 159328C DK 516182 A DK516182 A DK 516182A DK 516182 A DK516182 A DK 516182A DK 159328 C DK159328 C DK 159328C
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxy
- derivatives
- procedure
- synthesis inhibitors
- cholesterol synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/365—Nocardia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/872—Nocardia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18664181 | 1981-11-20 | ||
JP56186641A JPS5889191A (ja) | 1981-11-20 | 1981-11-20 | 3−ヒドロキシ−ml−236b誘導体の製造法 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK516182A DK516182A (da) | 1983-05-21 |
DK159328B DK159328B (da) | 1990-10-01 |
DK159328C true DK159328C (da) | 1991-02-25 |
Family
ID=16192138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK516182A DK159328C (da) | 1981-11-20 | 1982-11-19 | Fremgangsmaade til fremstilling af cholesterolsynteseinhiberende 3-hydroxy-ml-236b derivater, betegnet m-4 og m-4' |
Country Status (18)
Country | Link |
---|---|
US (1) | US4537859A (da) |
JP (1) | JPS5889191A (da) |
KR (1) | KR880002483B1 (da) |
AT (1) | AT387585B (da) |
AU (1) | AU551720B2 (da) |
BE (1) | BE895080A (da) |
CA (1) | CA1186647A (da) |
CH (1) | CH651065A5 (da) |
DE (1) | DE3242849A1 (da) |
DK (1) | DK159328C (da) |
ES (1) | ES517542A0 (da) |
FI (1) | FI70925C (da) |
FR (1) | FR2516935A1 (da) |
GB (1) | GB2111052B (da) |
IT (1) | IT1191235B (da) |
NL (1) | NL194373C (da) |
SE (1) | SE453996B (da) |
ZA (1) | ZA828535B (da) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE69602T1 (de) * | 1985-09-13 | 1991-12-15 | Sankyo Co | Hydroxy-ml-236b-derivate, deren herstellung und anwendung. |
US4940727A (en) * | 1986-06-23 | 1990-07-10 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
USRE36481E (en) * | 1986-06-23 | 2000-01-04 | Merck & Co., Inc. | HMG-CoA reductase inhibitors |
US5116870A (en) * | 1986-06-23 | 1992-05-26 | Merck & Co., Inc. | HMG-CoA reductase inhibitors |
US4833258A (en) * | 1987-02-17 | 1989-05-23 | Merck & Co., Inc. | Intermediates useful in the preparation of HMG-COA reductase inhibitors |
EP0306263B1 (en) * | 1987-09-02 | 1992-03-18 | Merck & Co. Inc. | Novel hmg-coa reductase inhibitors |
US4997848A (en) | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
US4997755A (en) * | 1988-04-15 | 1991-03-05 | Merck & Co., Inc. | HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455) |
EP0337548A3 (en) * | 1988-04-15 | 1991-08-14 | Merck & Co. Inc. | HMG-COA reductase inhibitors produced by nocardia SP. (MA6455)(ATCC 53695) |
US4963538A (en) * | 1988-06-29 | 1990-10-16 | Merck & Co., Inc. | 5-oxygenated HMG-CoA reductase inhibitors |
US5010105A (en) * | 1989-06-09 | 1991-04-23 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4970231A (en) * | 1989-06-09 | 1990-11-13 | Merck & Co., Inc. | 4-substituted HMG-CoA reductase inhibitors |
US5041562A (en) * | 1989-06-09 | 1991-08-20 | Merck & Co., Inc. | 3-keto HMG-CoA reductase inhibitors |
US4937259A (en) * | 1989-06-09 | 1990-06-26 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US5001241A (en) * | 1989-06-09 | 1991-03-19 | Merck & Co., Inc. | 3-KETO HMG-CoA reductase inhibitors |
US4997849A (en) * | 1989-06-23 | 1991-03-05 | Merck & Co., Inc. | Microbial transformation of simvastatin |
US4965200A (en) * | 1989-06-23 | 1990-10-23 | Merck & Co., Inc. | Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs |
US5112857A (en) * | 1990-09-04 | 1992-05-12 | Merck & Co., Inc. | Hmg-coa reductase inhibitor metabolites |
NZ250609A (en) * | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
US6043064A (en) * | 1993-10-22 | 2000-03-28 | Bristol-Myers Squibb Company | Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof |
US5942423A (en) * | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
SI9800144A (sl) * | 1998-05-21 | 1999-12-31 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Nov biotehnološki postopek pridobivanja 3-hidroksi-ML-236B derivatov poznanih kot M-4 in M-4' |
SI20305A (sl) * | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
CZ20012622A3 (cs) * | 1999-01-20 | 2002-01-16 | Kyowa Hakko Kogyo Co. Ltd. | Proces přípravy inhibitorů HMG-CoA reduktázy |
DE60042879D1 (de) * | 1999-01-29 | 2009-10-15 | Kyowa Hakko Bio Co Ltd | Verfahren zur herstellung eines hmg-coa reduktase hemmers |
US6682913B1 (en) | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
HUP9902352A1 (hu) | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
CZ20031166A3 (cs) * | 2000-10-05 | 2004-04-14 | Biogal Gyogyszergyar Rt | Sodná sůl pravastatinu, která v podstatě neobsahuje pravastatin lakton a epi-pravastatin a kompozice na její bázi |
JP3236282B1 (ja) * | 2000-10-16 | 2001-12-10 | 三共株式会社 | プラバスタチンを精製する方法 |
JP2003093045A (ja) * | 2001-09-26 | 2003-04-02 | Godo Shusei Co Ltd | 有用変換微生物 |
EP1496982A4 (en) * | 2002-04-16 | 2006-07-19 | Merck & Co Inc | SOLID FORMS OF SALTS WITH TYROSINE KINASE EFFECT |
US20040198800A1 (en) * | 2002-12-19 | 2004-10-07 | Geoffrey Allan | Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents |
US20040132771A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Inc | Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors |
BR0317521A (pt) | 2002-12-20 | 2005-11-16 | Pfizer Prod Inc | Formas de dosagem compreendendo um inibidor da cetp e um inibidor da redutase hmg-coa |
KR100470078B1 (ko) * | 2003-06-12 | 2005-02-04 | 씨제이 주식회사 | 컴팩틴을 프라바스타틴으로 전환할 수 있는 스트렙토마이세스 종(Streptomyces sp.)CJPV 975652 및 그를 이용한 프라바스타틴의 제조방법 |
CA2535359A1 (en) | 2003-08-21 | 2005-03-03 | Merck Frosst Canada Ltd. | Cathepsin cysteine protease inhibitors |
US20050101927A1 (en) * | 2003-09-11 | 2005-05-12 | Kimberly-Clark Worldwide, Inc. | Absorbent products comprising a moisturizing and lubricating composition |
WO2005051298A2 (en) | 2003-11-19 | 2005-06-09 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
TWI252253B (en) * | 2004-01-09 | 2006-04-01 | Chinese Petroleum Corp | A novel Pseudonocardia sp RMRC PAH4 and a process for bioconverting compactin into pravastatin using the same |
US20110217412A1 (en) * | 2004-07-30 | 2011-09-08 | Jinis Biopharmaceuticals Co. | Cholesterol lowering supplement and low cholesterol egg produced by using the same |
KR100637762B1 (ko) * | 2004-07-30 | 2006-10-23 | 주식회사 지니스 | 저콜레스테롤 란을 생산하기 위한 가금류용 사료첨가제 및 이를 이용한 저콜레스테롤 란의 생산방법 |
TWI307360B (en) | 2004-12-03 | 2009-03-11 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Process for constructing strain having compactin hydroxylation ability |
CA2590860C (en) | 2004-12-09 | 2011-05-03 | Merck & Co., Inc. | Estrogen receptor modulators |
PL1855674T3 (pl) | 2005-03-02 | 2015-01-30 | Merck Sharp & Dohme | Kompozycja do hamowania katepsyny K |
WO2006123182A2 (en) | 2005-05-17 | 2006-11-23 | Merck Sharp & Dohme Limited | Cyclohexyl sulphones for treatment of cancer |
TW200804345A (en) | 2005-08-30 | 2008-01-16 | Novartis Ag | Substituted benzimidazoles and methods of preparation |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
PL2010528T3 (pl) | 2006-04-19 | 2018-03-30 | Novartis Ag | 6-0-podstawione związki benzoksazolowe i benzotiazolowe i sposoby hamowania sygnalizacji csf-1r |
EP2946778A1 (en) | 2006-09-22 | 2015-11-25 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
EP2109608B1 (en) | 2007-01-10 | 2011-03-23 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
EA019951B1 (ru) | 2007-03-01 | 2014-07-30 | Новартис Аг | Ингибиторы киназы pim и способы их применения |
KR20100017866A (ko) | 2007-05-21 | 2010-02-16 | 노파르티스 아게 | Csf-1r 억제제, 조성물 및 사용 방법 |
EP3103791B1 (en) | 2007-06-27 | 2018-01-31 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
PL2222636T3 (pl) | 2007-12-21 | 2014-04-30 | Ligand Pharm Inc | Selektywne modulatory receptorów androgenowych (SARM) i ich zastosowania |
EP2265725B1 (en) * | 2008-04-25 | 2014-07-30 | Amorepacific Corporation | Method for preparing 7,5,3',4'-tetrahydroxyisoflavone using a biotransformation system |
WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
CN104945382B (zh) | 2009-10-14 | 2020-02-07 | 默沙东公司 | 提高p53活性的取代的哌啶和其用途 |
US8999957B2 (en) | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
JP6043285B2 (ja) | 2010-08-02 | 2016-12-14 | サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. | 低分子干渉核酸(siNA)を用いたカテニン(カドヘリン結合型タンパク質)β1(CTNNB1)遺伝子発現のRNA干渉媒介性阻害 |
CN108676800B (zh) | 2010-08-17 | 2022-11-11 | 瑟纳治疗公司 | 使用短干扰核酸(siNA)的乙型肝炎病毒(HBV)基因表达的RNA干扰介导的抑制 |
EP2608669B1 (en) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
EP2613782B1 (en) | 2010-09-01 | 2016-11-02 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
ES2663009T3 (es) | 2010-10-29 | 2018-04-10 | Sirna Therapeutics, Inc. | Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic) |
EP2654748B1 (en) | 2010-12-21 | 2016-07-27 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
WO2012112363A1 (en) | 2011-02-14 | 2012-08-23 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
CN103732592A (zh) | 2011-04-21 | 2014-04-16 | 默沙东公司 | 胰岛素样生长因子-1受体抑制剂 |
WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
EP3358013B1 (en) | 2012-05-02 | 2020-06-24 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
CN105050598B (zh) | 2012-09-28 | 2018-04-27 | 默沙东公司 | 作为erk抑制剂的新型化合物 |
CA2892361A1 (en) | 2012-11-28 | 2014-06-05 | Merck Sharp & Dohme Corp. | Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels |
AU2013361694B2 (en) | 2012-12-20 | 2017-10-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as HDM2 inhibitors |
WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
EP3041938A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Circular polynucleotides |
AU2014332250B2 (en) | 2013-10-08 | 2018-07-19 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
WO2015051479A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
US10441567B2 (en) | 2014-01-17 | 2019-10-15 | Ligand Pharmaceuticals Incorporated | Methods and compositions for modulating hormone levels |
WO2015120580A1 (en) | 2014-02-11 | 2015-08-20 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
EP3525785A4 (en) | 2016-10-12 | 2020-03-25 | Merck Sharp & Dohme Corp. | KDM5 INHIBITORS |
WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
CN115087638B (zh) | 2019-12-17 | 2023-11-24 | 默沙东公司 | Prmt5抑制剂 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3281330A (en) * | 1964-03-20 | 1966-10-25 | Upjohn Co | Microbiological process for the oxygenation of cycloalkanes |
US3392171A (en) * | 1964-03-20 | 1968-07-09 | Upjohn Co | 4-morpholino-4'-hydroxy bicyclohexyls |
DK149080C (da) * | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
-
1981
- 1981-11-20 JP JP56186641A patent/JPS5889191A/ja active Granted
-
1982
- 1982-11-16 AU AU90610/82A patent/AU551720B2/en not_active Expired
- 1982-11-16 CA CA000415650A patent/CA1186647A/en not_active Expired
- 1982-11-18 SE SE8206580A patent/SE453996B/sv not_active IP Right Cessation
- 1982-11-18 US US06/442,840 patent/US4537859A/en not_active Expired - Lifetime
- 1982-11-19 NL NL8204505A patent/NL194373C/nl not_active IP Right Cessation
- 1982-11-19 FI FI823978A patent/FI70925C/fi not_active IP Right Cessation
- 1982-11-19 DE DE19823242849 patent/DE3242849A1/de active Granted
- 1982-11-19 DK DK516182A patent/DK159328C/da not_active IP Right Cessation
- 1982-11-19 BE BE0/209527A patent/BE895080A/fr unknown
- 1982-11-19 CH CH6754/82A patent/CH651065A5/de not_active IP Right Cessation
- 1982-11-19 ZA ZA828535A patent/ZA828535B/xx unknown
- 1982-11-19 FR FR8219433A patent/FR2516935A1/fr active Granted
- 1982-11-19 ES ES517542A patent/ES517542A0/es active Granted
- 1982-11-20 KR KR8205250A patent/KR880002483B1/ko active
- 1982-11-22 GB GB08233267A patent/GB2111052B/en not_active Expired
- 1982-11-22 AT AT0425182A patent/AT387585B/de not_active IP Right Cessation
- 1982-11-22 IT IT68359/82A patent/IT1191235B/it active Protection Beyond IP Right Term
Also Published As
Publication number | Publication date |
---|---|
DE3242849C2 (da) | 1989-01-05 |
DK516182A (da) | 1983-05-21 |
AU551720B2 (en) | 1986-05-08 |
BE895080A (fr) | 1983-03-16 |
NL194373B (nl) | 2001-10-01 |
ES8402350A1 (es) | 1984-01-16 |
ES517542A0 (es) | 1984-01-16 |
DK159328B (da) | 1990-10-01 |
KR840002451A (ko) | 1984-07-02 |
NL194373C (nl) | 2002-02-04 |
JPH0371116B2 (da) | 1991-11-12 |
SE453996B (sv) | 1988-03-21 |
JPS5889191A (ja) | 1983-05-27 |
IT8268359A0 (it) | 1982-11-22 |
KR880002483B1 (ko) | 1988-11-19 |
SE8206580D0 (sv) | 1982-11-18 |
FI823978A0 (fi) | 1982-11-19 |
FI823978L (fi) | 1983-05-21 |
SE8206580L (sv) | 1983-05-21 |
ATA425182A (de) | 1988-07-15 |
IT1191235B (it) | 1988-02-24 |
CA1186647A (en) | 1985-05-07 |
FR2516935B1 (da) | 1985-02-08 |
AU9061082A (en) | 1983-05-26 |
DE3242849A1 (de) | 1983-06-01 |
ZA828535B (en) | 1983-10-26 |
GB2111052A (en) | 1983-06-29 |
FR2516935A1 (fr) | 1983-05-27 |
AT387585B (de) | 1989-02-10 |
FI70925C (fi) | 1986-10-27 |
CH651065A5 (de) | 1985-08-30 |
FI70925B (fi) | 1986-07-18 |
NL8204505A (nl) | 1983-06-16 |
US4537859A (en) | 1985-08-27 |
GB2111052B (en) | 1985-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK159328C (da) | Fremgangsmaade til fremstilling af cholesterolsynteseinhiberende 3-hydroxy-ml-236b derivater, betegnet m-4 og m-4' | |
DK577084A (da) | 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf | |
DK381485A (da) | 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf | |
DK433884A (da) | 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)-alkyl)piperazin-derivater og fremgangsmaade til fremstilling deraf | |
DK316784A (da) | 1,2,4-triazol-3-on-derivater og fremgangsmaade til fremstilling deraf | |
DK99382A (da) | Dichlorquinolinderivater og fremgangsmaade til fremstilling heraf | |
DK574581A (da) | Delta2-1,2,4-triazolin-5-on-derivater og fremgangsmaade til fremstilling heraf | |
DK163517C (da) | Fremgangsmaade til fremstilling af 4'-epidaunorubicin og 3',4'-diepidaunorubicin | |
DK468284A (da) | 1,2,4-triazolonderivater og fremgangsmaade til fremstilling deraf | |
DK165952C (da) | 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf | |
DK343684D0 (da) | Phenyletherderivater og fremgangsmaade til fremstilling deraf | |
DK52885D0 (da) | 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf | |
DK401385A (da) | 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf | |
DK596784D0 (da) | Phenylderivater og fremgangsmaade til fremstilling deraf | |
DK445784A (da) | Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf | |
DK492785A (da) | Fremgangsmaade til fremstilling af milbemycinderivater og forbindelser til anvendelse ved fremgangsmaaden | |
DK446685D0 (da) | Carbapenemderivater og fremgangsmaade til fremstilling deraf | |
DK389484A (da) | Fremgangsmaade til fremstilling af 2,3-dihydrobenzopyranonderivater | |
DK237287D0 (da) | Propargyloxybenzen-derivater, fremgangsmaade til fremstilling deraf og praeparater med fungicid virkning indeholdende disse derivater | |
DK182585D0 (da) | Fosfomycinderivat og fremgangsmaade til fremstilling deraf | |
DK191982A (da) | 2,4-dioxacyklohexanonderivat og fremgangsmaade til fremstilling deraf | |
DK151022C (da) | Analogifremgangsmaade til fremstilling af apovincaminol-3',4',5'-trimethoxybenzoatderivater og apovincaminolderivater til anvendelse ved fremgangsmaadenn | |
DK596884D0 (da) | Phenylderivater og fremgangsmaade til fremstilling deraf | |
DK160832C (da) | Heterocycliske bornan-derivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne forbindelser | |
DK216585D0 (da) | Beta-carbolin-3-oxadiazolylderivater og fremgangsmaade til fremstilling af samme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |